Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin

Robert G. Gish; Camillo Porta; Lucian Lazar; Paul Ruff; Ronald Feld; Adina Croitoru; Lynn Feun; Krzysztof Jeziorski; John Leighton; José Gallo; Gerard T. Kennealey

doi:10.1200/JCO.2006.08.4046

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin

Robert G. Gish
, Camillo Porta
, Lucian Lazar
, Paul Ruff
, Ronald Feld
, Adina Croitoru
, Lynn Feun
, Krzysztof Jeziorski
, John Leighton
, José Gallo
, Gerard T. Kennealey

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	3069-75
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	25
Issue number	21
DOIs	https://doi.org/10.1200/JCO.2006.08.4046
State	Published - Jul 20 2007
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

Terminally Ill
Drug Administration Schedule
Risk Assessment
Humans
Middle Aged
Male
Quinazolines/therapeutic use
Carcinoma, Hepatocellular/drug therapy
Dose-Response Relationship, Drug
Maximum Tolerated Dose
Liver Neoplasms/drug therapy
Survival Analysis
Quality of Life
Adult
Female
Aged
Infusions, Intravenous
Neoplasm Staging
Doxorubicin/therapeutic use
Palliative Care/methods

Access to Document

10.1200/JCO.2006.08.4046

OpenUrl availability

Full text

Cite this

Gish, R. G., Porta, C., Lazar, L., Ruff, P., Feld, R., Croitoru, A., Feun, L., Jeziorski, K., Leighton, J., Gallo, J., & Kennealey, G. T. (2007). Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. Journal of Clinical Oncology, 25(21), 3069-75. https://doi.org/10.1200/JCO.2006.08.4046

Gish, RG, Porta, C, Lazar, L, Ruff, P, Feld, R, Croitoru, A, Feun, L, Jeziorski, K, Leighton, J, Gallo, J & Kennealey, GT 2007, 'Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin', Journal of Clinical Oncology, vol. 25, no. 21, pp. 3069-75. https://doi.org/10.1200/JCO.2006.08.4046

@article{2e5f061221924415892a44844c022e2e,

title = "Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin",

keywords = "Terminally Ill, Drug Administration Schedule, Risk Assessment, Humans, Middle Aged, Male, Quinazolines/therapeutic use, Carcinoma, Hepatocellular/drug therapy, Dose-Response Relationship, Drug, Maximum Tolerated Dose, Liver Neoplasms/drug therapy, Survival Analysis, Quality of Life, Adult, Female, Aged, Infusions, Intravenous, Neoplasm Staging, Doxorubicin/therapeutic use, Palliative Care/methods",

author = "Gish, \{Robert G.\} and Camillo Porta and Lucian Lazar and Paul Ruff and Ronald Feld and Adina Croitoru and Lynn Feun and Krzysztof Jeziorski and John Leighton and Jos{\'e} Gallo and Kennealey, \{Gerard T.\}",

year = "2007",

month = jul,

day = "20",

doi = "10.1200/JCO.2006.08.4046",

language = "English",

volume = "25",

pages = "3069--75",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "21",

}

TY - JOUR

T1 - Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin

AU - Gish, Robert G.

AU - Porta, Camillo

AU - Lazar, Lucian

AU - Ruff, Paul

AU - Feld, Ronald

AU - Croitoru, Adina

AU - Feun, Lynn

AU - Jeziorski, Krzysztof

AU - Leighton, John

AU - Gallo, José

AU - Kennealey, Gerard T.

PY - 2007/7/20

Y1 - 2007/7/20

KW - Terminally Ill

KW - Drug Administration Schedule

KW - Risk Assessment

KW - Humans

KW - Middle Aged

KW - Male

KW - Quinazolines/therapeutic use

KW - Carcinoma, Hepatocellular/drug therapy

KW - Dose-Response Relationship, Drug

KW - Maximum Tolerated Dose

KW - Liver Neoplasms/drug therapy

KW - Survival Analysis

KW - Quality of Life

KW - Adult

KW - Female

KW - Aged

KW - Infusions, Intravenous

KW - Neoplasm Staging

KW - Doxorubicin/therapeutic use

KW - Palliative Care/methods

UR - https://www.scopus.com/pages/publications/34547662913

UR - https://www.scopus.com/pages/publications/34547662913#tab=citedBy

UR - https://www.mendeley.com/catalogue/5b51555d-75e6-33cd-b288-e485a2e19704/

U2 - 10.1200/JCO.2006.08.4046

DO - 10.1200/JCO.2006.08.4046

M3 - Article

C2 - 17634485

AN - SCOPUS:34547662913

SN - 0732-183X

VL - 25

SP - 3069

EP - 3075

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 21

ER -

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this